| http://www.w3.org/ns/prov#value | - U.S.-based drug company Gilead Sciences has filed a patent for its new Hepatitis C drug compound in Ireland (according to the Wall Street Journal) where income on patent royalties is exempt; The move is an attempt to avoid paying U.S. taxes, while enjoying the taxpayer-funded research that makes their business possible, says AHF
|
